Jun Zhu (Ju Zhu)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 39

Top Venues

Cancer medicine

Bone marrow transplantation

Journal of hematology & oncology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of zeste homolog 2 inhibitor SHR2554 in relapsed or refractory peripheral T-cell lymphoma: data from the first-in-human phase 1 study. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Yuqin Song, Zhengming Jin, Zhi-Ming Li, Yan-Yan Liu, Lanfang Li, Chuan He, Hang Su, Hui Zhou, Kunyan Li, Siguo Hao, Xuelan Zuo, Jianyuan Wu, Xiaojian Zhu, Meng Wu, Xiuhua Sun, Junyuan Qi, Zhen Cai, Zhenjiang Li, Yijing Li, Yanhua Huang, Jie Shen, Zhenyu Xiao, Jun Zhu
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Chen Zhang, Jili Deng, Yan Xie, Lan Mi, Weiping Liu, Xiaopei Wang, Linjun Zhao, Yuqin Song, Jun Zhu
Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma. Cancer medicine (2023)
Jia-Xin Liu, Xin Liu, Yong Yang, Wei-Ping Liu, Ying Wang, Xia He, Li-Ling Zhang, Bao-Lin Qu, Li-Ting Qian, Xiao-Rong Hou, Xue-Ying Qiao, Hua Wang, Gao-Feng Li, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Hang Su, Yu-Jing Zhang, Jun Zhu, Shu-Nan Qi, Ye-Xiong Li, Yu-Qin Song
Clinical characteristics, treatment, and survival of 30 patients with gastrointestinal natural killer/T-cell lymphoma. Cancer reports (Hoboken, N.J.) (2023)
Weiping Liu, Ningjing Lin, Xinqin Feng, Yan Xie, Chong You, Xiao-Hua Zhou, Yuqin Song, Jun Zhu
Long-term survival benefit of anti-PD-1 therapy in patients with relapsed or refractory classical Hodgkin lymphoma. Signal transduction and targeted therapy 8 (1) (2023)
Chen Zhang, Jili Deng, Yan Xie, Lan Mi, Weiping Liu, Xiaopei Wang, Linjun Zhao, Yuqin Song, Jun Zhu
Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma. Cancer medicine (2023)
Yuqin Song, Ke-Shu Zhou, Dehui Zou, Dengju Li, Jian-da Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Dao-Bin Zhou, Constantine S Tam, David Simpson, Michael L Wang, Tycel J Phillips, Stephen Samuel Opat, Cheng Fang, Shaohui Sun, Jun Zhu
Long-term outcomes of second-line versus later-line zanubrutinib treatment in patients with relapsed/refractory mantle cell lymphoma: An updated pooled analysis. Cancer medicine (2023)
Li-Juan Deng, Ke-Shu Zhou, Li-Hong Liu, Ming-Zhi Zhang, Zhi-Ming Li, Chun-Yan Ji, Wei Xu, Ting Liu, Bing Xu, Xin Wang, Su-Jun Gao, Hui-Lai Zhang, Han Yan, Yan Li, Ying Cheng, Hai-Yan Yang, Jun-Ning Cao, Zunmin Zhu, Jian-Da Hu, Wei Zhang, Hong-Mei Jing, Kai-Yang Ding, Xiang-Yang Zhang, Renbin Zhao, Bin Zhang, Ya-Min Tian, Yong-Ping Song, Yu-Qin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study. Blood advances (2023)
Lijuan Deng, Zhi-Ming Li, Huilai Zhang, Haiwen Huang, Jian-da Hu, Lihong Liu, Ting Liu, Jie Jin, Zunmin Zhu, Wenyu Li, Zhenqian Huang, Wenrong Huang, Ke-Shu Zhou, Haiyan Yang, Mingzhi Zhang, Kaiyang Ding, Hui Zhou, Han Yan, Yuerong Shuang, Junning Cao, Sujun Gao, Dengju Li, Zimin Sun, Qingyuan Zhang, Shuhua Yi, Chun-Yan Ji, Liansheng Zhang, Cheng Hou, Yue Du, Weige Wang, Renbin Zhao, Yuqin Song, Jun Zhu
Orelabrutinib for the treatment of relapsed or refractory marginal zone lymphoma: A phase 2, multicenter, open-label study. American journal of hematology (2023)
Hongye Gao, Xiaogan Wang, Yumei Lai, Chen Zhang, Lan Mi, Xinqiang Ji, Xiaopei Wang, Yu-Qin Song, Jun Zhu, Weiping Liu
Different situations of identifying second primary malignant tumors in lymphoma patients with synchronous solid tumors. Cancer medicine (2023)
Chen Zhang, Jili Deng, Yan Xie, Lan Mi, Weiping Liu, Xiaopei Wang, Linjun Zhao, Yuqin Song, Jun Zhu
Single or tandem autologous stem cell transplantation for treating Chinese patients with refractory/relapsed classical Hodgkin lymphoma. Cancer medicine (2023)
Meng Wu, Fengrong Wang, Shihua Zhao, Yajun Li, Wenrong Huang, Bo Nie, Haisheng Liu, Xiaoqian Liu, Wei Li, Haifeng Yu, Kun Yi, Fei Dong, Yujun Dong, Chenglu Yuan, Xuehong Ran, Xiubin Xiao, Weiping Liu, Jun Zhu
Autologous hematopoietic stem cell transplantation improves survival outcomes in peripheral T-cell lymphomas: a multicenter retrospective real-world study. Annals of hematology (2023)
Hui Yu, Lan Mi, Weimin Zhang, Yingying Ye, Miaomiao Li, Dingyao Hu, Jiaowu Cao, Dedao Wang, Xiaogan Wang, Ning Ding, Yuqin Song, Jun Zhu
Ibrutinib combined with low-dose histone deacetylases inhibitor chidamide synergistically enhances the anti-tumor effect in B-cell lymphoma. Hematological oncology (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Zhitao Ying, Yan Xie, Wen Zheng, Weiping Liu, Ningjing Lin, Meifeng Tu, Xiaopei Wang, Lingyan Ping, Lijuan Deng, Chen Zhang, Meng Wu, Feier Feng, Tingting Du, Yongjing Tang, Fang Su, Ziyu Guo, James Li, Yuqin Song, Jun Zhu
Efficacy and safety of relmacabtagene autoleucel, an anti-CD19 chimeric antigen receptor T cell, in relapsed/refractory B-cell non-Hodgkin's lymphoma: 2-year results of a phase 1 trial. Bone marrow transplantation (2022)
Yuqin Song, Mingyuan Sun, Junyuan Qi, Wei Xu, Jian-Feng Zhou, Dengju Li, Jianyong Li, Lugui Qiu, Chenmu Du, Haiyi Guo, Jane Huang, Zhiyu Tang, Ying Ou, Binghao Wu, Yiling Yu, Jun Zhu
A two-part, single-arm, multicentre, phase I study of zanubrutinib, a selective Bruton tyrosine kinase inhibitor, in Chinese patients with relapsed/refractory B-cell malignancies. British journal of haematology 198 (1) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Miaomiao Li, Hui Yu, Fei Qi, Yingying Ye, Dingyao Hu, Jiaowu Cao, Dedao Wang, Lan Mi, Zhengyi Wang, Ning Ding, Lingyan Ping, Shaokun Shu, Jun Zhu
Anti-CD47 immunotherapy in combination with BCL-2 inhibitor to enhance anti-tumor activity in B-cell lymphoma. Hematological oncology 40 (4) (2022)
Xuan Zheng, Bao-Lin Qu, Xin Liu, Qiu-Zi Zhong, Li-Ting Qian, Yong Yang, Xiao-Rong Hou, Xue-Ying Qiao, Hua Wang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Xi-Mei Zhang, Hang Su, Yu-Qin Song, Jun Zhu, Yu-Jing Zhang, Hui-Qiang Huang, Ying Wang, Fan Chen, Lin Yin, Xia He, Li-Ling Zhang, Ye-Xiong Li, Shu-Nan Qi
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database. EJHaem 4 (1) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation (2022)
Xuan Zheng, Bao-Lin Qu, Xin Liu, Qiu-Zi Zhong, Li-Ting Qian, Yong Yang, Xiao-Rong Hou, Xue-Ying Qiao, Hua Wang, Yuan Zhu, Jian-Zhong Cao, Jun-Xin Wu, Tao Wu, Su-Yu Zhu, Mei Shi, Hui-Lai Zhang, Xi-Mei Zhang, Hang Su, Yu-Qin Song, Jun Zhu, Yu-Jing Zhang, Hui-Qiang Huang, Ying Wang, Fan Chen, Lin Yin, Xia He, Li-Ling Zhang, Ye-Xiong Li, Shu-Nan Qi
Characteristics and prognosis of distant metastasis after primary treatment for early-stage extranodal nasal-type natural killer/T-cell lymphoma from the China Lymphoma Collaborative Group database. EJHaem 4 (1) (2022)
Yuqin Song, Ke-Shu Zhou, Dehui Zou, Jianfeng Zhou, Jianda Hu, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Jie Jin, Fangfang Lv, Ru Feng, Sujun Gao, Haiyi Guo, Lei Zhou, Jane Huang, William Novotny, Pil Kim, Yiling Yu, Binghao Wu, Jun Zhu
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study. Blood 139 (21) (2022)
Jiao Li, Hui Yu, Xing Wang, Yingying Ye, Wei Fang, Ning Ding, Lan Mi, Lingyan Ping, Xiaogan Wang, Yuqin Song, Jun Zhu
The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Weiping Liu, Lingyan Ping, Yan Xie, Yingli Sun, Tingting Du, Yi Niu, Galia Cisternas, Funan Huang, Jose Garcia-Vargas, Barrett H Childs, Aruna Mehra, Susanne Reschke, Xiaopei Wang, Yuqin Song, Jun Zhu
A phase I pharmacokinetic study of copanlisib in Chinese patients with relapsed indolent non-Hodgkin lymphoma. Cancer chemotherapy and pharmacology 89 (6) (2022)
Zhitao Ying, Dehui Zou, Haiyan Yang, Jianqiu Wu, Ye Guo, Wenyu Li, Hui Liu, Chris Wang, Laura Ma, Su Yang, Zisong Zhou, Yun Qin, Yu-Qin Song, Jun Zhu
Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial. American journal of hematology 97 (12) (2022)
Weiping Liu, Jie Ji, Dehui Zou, Yang Cao, Yajing Xu, Jian Zhou, Sujun Gao, Fengrong Wang, Wenming Chen, Juan Du, Hui Zhou, Fuling Zhou, Jimin Shi, Xi Zhang, Jianmin Yang, Hongmei Jing, Zhongxing Jiang, Hui Liu, Caixia Li, Hongling Peng, Songfu Jiang, Xiaolei Wei, Pengcheng He, Yao Liu, Haiyan Yang, Zengjun Li, Xiaobing Huang, Lin Liu, Lijing Shen, Chuanfang Liu, Yu-Qin Song, Lugui Qiu, Xiaopei Wang, Jun Ma, Jun Zhu
Autologous hematopoietic stem cell transplantation activity for lymphoma and multiple myeloma in China. Bone marrow transplantation 58 (3) (2022)
Jiao Li, Hui Yu, Xing Wang, Yingying Ye, Wei Fang, Ning Ding, Lan Mi, Lingyan Ping, Xiaogan Wang, Yuqin Song, Jun Zhu
The Serum- and Glucocorticoid-Inducible Kinase 1 (SGK1) as a Novel Therapeutic Target in Mantle Cell Lymphoma. Cancer control : journal of the Moffitt Cancer Center 29 (2022)
Yingying Ye, Ning Ding, Lan Mi, Yunfei Shi, Weiping Liu, Yuqin Song, Shaokun Shu, Jun Zhu
Correlation of mutational landscape and survival outcome of peripheral T-cell lymphomas. Experimental hematology & oncology 10 (1) (2021)
Miaomiao Li, Ning Ding, Lan Mi, Yunfei Shi, Xinhua Du, Yuting Yi, Ling Yang, Weiping Liu, Jun Zhu
Liquid biopsy in diffuse large B-cell lymphoma: utility in cell origin determination and survival prediction in Chinese patients. Leukemia & lymphoma (2021)
Jianqiu Wu, Yuqin Song, Xinchuan Chen, Tongyu Lin, Junning Cao, Yanyan Liu, Yaozhong Zhao, Jie Jin, Haiwen Huang, Jianda Hu, Jun Luo, Liling Zhang, Hongwei Xue, Qingyuan Zhang, Weiwei Wang, Chunxia Chen, Jifeng Feng, Jun Zhu
Camrelizumab for relapsed or refractory classical Hodgkin lymphoma: Extended follow-up of the multicenter, single-arm, Phase 2 study. International journal of cancer (2021)
Weiping Liu, Xinqiang Ji, Yu-Qin Song, Xiaopei Wang, Wen Zheng, Ningjing Lin, Meifeng Tu, Yan Xie, Lingyan Ping, Zhitao Ying, Chen Zhang, Lijuan Deng, Meng Wu, Feier Feng, Xin Leng, Yingli Sun, Tingting Du, Jun Zhu
Improving survival of 3760 patients with lymphoma: Experience of an academic center over two decades. Cancer medicine 9 (11) (2020)
Xiaogan Wang, Yuqin Song, Wei Chen, Ning Ding, Weiping Liu, Yan Xie, Yinan Wang, Jun Zhu, Changqing Zeng
Germline variants of DNA repair genes in early onset mantle cell lymphoma. Oncogene 40 (3) (2020)
Zhitao Ying, Haiyan Yang, Ye Guo, Wenyu Li, Dehui Zou, Dao-Bin Zhou, Zhao Wang, Mingzhi Zhang, Jianqiu Wu, Hui Liu, Pian Zhang, Su Yang, Zisong Zhou, Hongxia Zheng, Yuqin Song, Jun Zhu
Relmacabtagene autoleucel (relma-cel) CD19 CAR-T therapy for adults with heavily pretreated relapsed/refractory large B-cell lymphoma in China. Cancer medicine 10 (3) (2020)
Yan Xie, Xiaopei Wang, Xin Leng, Wen Zheng, Lingyan Ping, Chen Zhang, Weiping Liu, Lijuan Deng, Meng Wu, Yuqin Song, Jun Zhu
High-dose chemotherapy followed by autologous stem cell transplantation for patients with refractory/relapsed classical Hodgkin lymphoma: a single center experience from China. Annals of hematology 99 (3) (2020)
Weiping Liu, Meng Wu, Yan Xie, Chen Zhang, Lingyan Ping, Feier Feng, Xin Leng, Lan Mi, Xiaopei Wang, Jun Zhu, Yu-Qin Song
Autologous hematopoietic stem cell transplantation with inadequate stem cell dose in patients with non-Hodgkin lymphoma. Leukemia & lymphoma 62 (2) (2020)
Weiping Liu, Jiangmei Liu, Yuqin Song, Xinying Zeng, Xiaopei Wang, Lan Mi, Cai Cai, Lijun Wang, Jun Ma, Jun Zhu, null null, null null
Burden of lymphoma in China, 2006-2016: an analysis of the Global Burden of Disease Study 2016. Journal of hematology & oncology 12 (1) (2019)
Weiping Liu, Jiangmei Liu, Yuqin Song, Xiaopei Wang, Maigeng Zhou, Lijun Wang, Jun Ma, Jun Zhu, null null
Mortality of lymphoma and myeloma in China, 2004-2017: an observational study. Journal of hematology & oncology 12 (1) (2019)
Zhitao Ying, Xue F Huang, Xiaoyu Xiang, Yanling Liu, Xi Kang, Yuqin Song, Xiaokai Guo, Hanzhi Liu, Ning Ding, Tingting Zhang, Panpan Duan, Yufu Lin, Wen Zheng, Xiaopei Wang, Ningjing Lin, Meifeng Tu, Yan Xie, Chen Zhang, Weiping Liu, Lijuan Deng, Shunyu Gao, Lingyan Ping, Xuejuan Wang, Nina Zhou, Junqing Zhang, Yulong Wang, Songfeng Lin, Mierzhati Mamuti, Xueyun Yu, Lizhu Fang, Shuai Wang, Haifeng Song, Guan Wang, Lindsey Jones, Jun Zhu, Si-Yi Chen
A safe and potent anti-CD19 CAR T cell therapy. Nature medicine 25 (6) (2019)
Cunzhen Shi, Xiangqun Li, Xiaogan Wang, Ning Ding, Lingyan Ping, Yunfei Shi, Lan Mi, Yumei Lai, Yuqin Song, Jun Zhu
The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma. Journal of hematology & oncology 11 (1) (2018)

Jun Zhu.css-eqlu8i{font-size:small;padding-left:4px;} (Ju Zhu)

Publication Activity (10 Years)

Top Topics

Top Venues

Jun Zhu (Ju Zhu)